Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gilbert

Showing results (971-980 of 1,139) with videos related to

Pageof 114
Sort By:
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
Vaccine|September 6, 2001
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzeesJ Schneider, J A Langermans, S C Gilbert, et al.
International Journal of Obesity (2005)|November 26, 2008
Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional StudyL Béghin, M Castera, Y Manios, et al.
Vaccine|August 4, 2009
Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccinesKaren Colbjørn Larsen, Alexandra J Spencer, Anna L Goodman, et al.
Vaccine|December 1, 2015
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoterNaif Khalaf Alharbi, Alexandra J Spencer, Ahmed M Salman, et al.
Journal of Human Evolution|July 27, 2016
Internal carotid arterial canal size and scaling in Euarchonta: Re-assessing implications for arterial patency and phylogenetic relationships in early fossil primatesDoug M Boyer, E Christopher Kirk, Mary T Silcox, et al.
Plos Clinical Trials|October 21, 2006
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaPhilip Bejon, Jedidah Mwacharo, Oscar Kai, et al.
Blood|January 10, 2009
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Robert C Carlisle, Ying Di, Anna M Cerny, et al.
The American Journal of Tropical Medicine and Hygiene|March 16, 2007
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic areaEgeruan B Imoukhuede, Laura Andrews, Paul Milligan, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Pageof 114

Showing results (971-980 of 1,139) with videos related to

Sort By:
Pageof 114
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
Vaccine|September 6, 2001
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzeesJ Schneider, J A Langermans, S C Gilbert, et al.
International Journal of Obesity (2005)|November 26, 2008
Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional StudyL Béghin, M Castera, Y Manios, et al.
Vaccine|August 4, 2009
Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccinesKaren Colbjørn Larsen, Alexandra J Spencer, Anna L Goodman, et al.
Vaccine|December 1, 2015
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoterNaif Khalaf Alharbi, Alexandra J Spencer, Ahmed M Salman, et al.
Journal of Human Evolution|July 27, 2016
Internal carotid arterial canal size and scaling in Euarchonta: Re-assessing implications for arterial patency and phylogenetic relationships in early fossil primatesDoug M Boyer, E Christopher Kirk, Mary T Silcox, et al.
Plos Clinical Trials|October 21, 2006
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaPhilip Bejon, Jedidah Mwacharo, Oscar Kai, et al.
Blood|January 10, 2009
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Robert C Carlisle, Ying Di, Anna M Cerny, et al.
The American Journal of Tropical Medicine and Hygiene|March 16, 2007
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic areaEgeruan B Imoukhuede, Laura Andrews, Paul Milligan, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Pageof 114